Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held June 12, 2020
June 12, 2020 09:32 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, June 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with the results as follows: The Annual Report for 2019 was adopted. The Board...
Bavarian Nordic A/S – Orientering om forløb af ordinær generalforsamling den 12. juni 2020
June 12, 2020 09:32 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 12. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ordinær generalforsamling med følgende resultater: Årsrapporten for 2019 blev godkendt. Bestyrelsens forslag om,...
Bavarian Nordic offentliggør toplinjeresultater fra fase 1-forsøg med vaccine mod hesteencephalit virus
June 08, 2020 01:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. juni 2020 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag toplinjeresultater fra det første forsøg i mennesker med den forebyggende vaccinekandidat MVA-BN® WEV mod tre...
Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
June 08, 2020 01:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, June 8, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today topline results from the the first-in-human trial of MVA-BN® WEV, a prophylactic vaccine candidate...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
May 29, 2020 14:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 29. maj 2020 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
May 29, 2020 14:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 29, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons...
Bavarian Nordic meddeler at Janssen har modtaget positiv anbefaling fra det Europæiske Lægemiddelagentur vedrørende godkendelse af ebolavaccinen
May 29, 2020 06:42 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 29. maj 2020 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabets strategiske partner, Janssen Pharmaceutical Companies of Johnson & Johnson, har modtaget en positiv...
Bavarian Nordic Announces that Janssen has Received Positive CHMP Opinion for its Investigational Preventative Ebola Vaccine Regimen
May 29, 2020 06:42 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 29, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that its strategic partner Janssen Pharmaceutical Companies of Johnson & Johnson has received a...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
May 25, 2020 10:06 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, May 25, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
May 25, 2020 10:06 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 25. maj 2020 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...